PHIO - Phio Pharmaceuticals Corp Quarterly EPS earnings growth

PHIO (RXi Pharmaceuticals) - company brandmark

Phio Pharmaceuticals' scientific authority in developing INTASYL RNA therapy contributes to minimal environmental impact due to small-scale production. The quarterly EPS growth trajectory visualizes this connection, where 18.40 records a new level. However, patent conflicts and complexities in regenerative research constrain financial stability, completing the overall fundamental picture of the business.

Phio Pharmaceuticals Corp. (PHIO) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/15/2026

PHIO (phiopharma.com): analytical breakdowns and indicator data

- share price and expert price forecast:
Stock Price RXi Pharmaceuticals|PHIO - Fair Value Consensus
- market capitalization statistics:
Market Capitalization PHIO|PHIO - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Phio Pharmaceuticals|PHIO - Accounting Value of Company|Market Value to Book Value Ratio phiopharma.com|PHIO - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Phio Pharmaceuticals|PHIO - Long-Term Debt to Capital|Short-Term Debt to Capital RXi Pharmaceuticals|PHIO - Company Total Debt|Debts to Book Capitalization RXi Pharmaceuticals|PHIO - Long-Term Debt|Company Current Liabilities Phio Pharmaceuticals|Quick Liquidity Indicator phiopharma.com
- earnings and market multiples details:
PHIO - Profit After Payment of Taxes|Projected Future Earnings Phio Pharmaceuticals|PHIO - Business Payback Period|Forward P/E Multiple RXi Pharmaceuticals|PHIO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple PHIO|PHIO - Operating profit EBITDA|Earnings per share for the last twelve months Phio Pharmaceuticals|PHIO - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months phiopharma.com|PHIO - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Phio Pharmaceuticals
- sales revenue and business income indicators:
PHIO - Company Annual Revenue|Projected Sales Volume RXi Pharmaceuticals|PHIO - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Phio Pharmaceuticals Corp|PHIO - Annual Revenue Growth (Last Twelve Months)
Basic company analysis:Phio Pharmaceuticals Corp - PHIO
Flagship merchandise of Phio Pharmaceuticals

To identify fundamentally resilient assets, investors evaluate net profit per share dynamics, which measure the rate of change in EPS between quarters and signal the viability of cash flows. By analyzing the quarterly EPS history, one can determine how effectively the INTASYL platform and the RNA interference patent protection of Phio Pharmaceuticals (PHIO) convert into financial stability and growth in shareholder value.

Analysis of competing companies

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Year-over-year earnings per share growth for the last twelve months Benitec Biopharma BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|RCKT - Year-over-year earnings per share growth for the last twelve months|4dmoleculartherapeutics.com (FDMT) - Year-over-year net earnings per share growth for the last 12 months|lexeotx.com (LXEO) - Year-over-year earnings per share growth for the last twelve months|Korro Bio, Inc (KRRO) - Quarterly EPS earnings growth|EDIT (editasmedicine.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SLN (silence-therapeutics.com)|Year-over-year earnings per share growth for the last twelve months proqr.com (PRQR)|Codexis - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth SGMO (Sangamo Therapeutics)|Quarterly EPS earnings growth nautilus.bio NAUT|Metagenomi Inc. - Quarterly EPS earnings growth|DTIL (Precision BioSciences Inc.) - Year-over-year earnings per share growth for the last 12 months|GBIO: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Boundless Bio, Inc (BOLD)|XCUR (Exicure) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Imunon (IMNN)|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)